Mucosal resident memory CD4 T cells in protection and immunopathology

Frontiers in Immunology

Volumn 5, Issue JUL, 2014, Pages

  Turner, Damian Lanz ^a   Farber, Donna L ^a  

^a NewYork Presbyterian Hospital   (United States)

Author keywords

Intestine; Lung; Mucosal immunity; T cell memory; Tissue homing

Indexed keywords

EID: 84905639286     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00331     Document Type: Review

References (125)

1. Masopust D, Vezys V, Marzo AL, Lefrancois L. Preferential localization of effector memory cells in nonlymphoid tissue. Science doi: 10.1126/science.1058867 (2001) 291(5512):2413-7.
2. Klonowski KD, Williams KJ, Marzo AL, Blair DA, Lingenheld EG, Lefrancois L. Dynamics of blood-borne CD8 memory T cell migration in vivo. Immunity doi:10.1016/S1074-7613(04)00103-7 (2004) 20(5):551-62.
3. Jiang X, Clark RA, Liu L, Wagers AJ, Fuhlbrigge RC, Kupper TS. Skin infection generates non-migratory memory CD8+ TRM cells providing global skin immunity. Nature doi:10.1038/nature10851 (2012) 483(7388):227-31.
4. Schenkel JM, Fraser KA, Masopust D. Cutting edge: resident memory CD8 T cells occupy frontline niches in secondary lymphoid organs. J Immunol doi:10.4049/jimmunol.1400003 (2014) 192(7):2961-4.
5. Wakim LM, Woodward-Davis A, Bevan MJ. Memory T cells persisting within the brain after local infection show functional adaptations to their tissue of residence. Proc Natl Acad Sci U S A doi:10.1073/pnas.1010201107 (2010) 107(42):17872-9.
6. Anderson KG, Sung H, Skon CN, Lefrancois L, Deisinger A, Vezys V, et al. Cutting edge: intravascular staining redefines lung CD8 T cell responses. J Immunol doi:10.4049/jimmunol.1201682 (2012) 189(6):2702-6.
7. Shin H, Iwasaki A. A vaccine strategy that protects against genital herpes by establishing local memory T cells. Nature doi:10.1038/nature11522 (2012) 491(7424):463-7.
8. Masopust D, Picker LJ. Hidden memories: frontline memory T cells and early pathogen interception. J Immunol doi:10.4049/jimmunol.1102695 (2012) 188(12):5811-7.
9. Mueller SN, Gebhardt T, Carbone FR, Heath WR. Memory T cell subsets, migration patterns, and tissue residence. Annu Rev Immunol doi:10.1146/annurev-immunol-032712-095954 (2013) 31:137-61.
10. Sathaliyawala T, Kubota M, Yudanin N, Turner D, Camp P, Thome JJ, et al. Distribution and compartmentalization of human circulating and tissue-resident memory T cell subsets. Immunity doi:10.1016/j.immuni.2012.09.020 (2013) 38(1):187-97.
11. Ganusov VV,De Boer RJ. Do most lymphocytes in humans really reside in the gut? Trends Immunol doi:10.1016/j.it.2007.08.009 (2007) 28(12):514-8.
12. Turner DL, Bickham KL, Thome JJ, Kim CY, D'Ovidio F, Wherry EJ, et al. Lung niches for the generation and maintenance of tissue-resident memory T cells. Mucosal Immunol doi:10.1038/mi.2013.67 (2014) 7(3):501-10.
13. Teijaro JR, Turner D, Pham Q, Wherry EJ, Lefrancois L, Farber DL. Cutting edge: tissue-retentive lung memory CD4 T cells mediate optimal protection to respiratory virus infection. J Immunol doi:10.4049/jimmunol.1102243 (2011) 187(11):5510-4.
14. Nakanishi Y, Lu B, Gerard C, Iwasaki A. CD8(+) T lymphocyte mobilization to virus-infected tissue requires CD4(+) T-cell help. Nature doi:10.1038/nature08511 (2009) 462(7272):510-3.
15. Sakai S, Kauffman KD, Schenkel JM, McBerry CC, Mayer-Barber KD, Masopust D, et al. Cutting edge: control of Mycobacterium tuberculosis infection by a subset of lung parenchyma-homing CD4 T cells. J Immunol doi:10.4049/jimmunol.1400019 (2014) 192(7):2965-9.
16. Sallusto F, Geginat J, Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol doi:10.1146/annurev.immunol.22.012703.104702 (2004) 22:745-63.
17. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature doi:10.1038/44385 (1999) 401(6754):708-12.
18. Ahmadzadeh M, Hussain SF, Farber DL. Effector CD4 T cells are biochemically distinct from the memory subset: evidence for long-term persistence of effectors in vivo. J Immunol (1999) 163(6):3053-63.
19. Ahmadzadeh M, Hussain SF, Farber DL. Heterogeneity of the memory CD4 T cell response: persisting effectors and resting memory T cells. J Immunol doi:10.4049/jimmunol.166.2.926 (2001) 166(2):92635.
20. Usherwood EJ, Hogan RJ, Crowther G, Surman SL, Hogg TL, Altman JD, et al. Functionally heterogeneous CD8(+) T-cell memory is induced by Sendai virus infection of mice. J Virol (1999) 73(9):7278-86.
21. Reinhardt RL, Khoruts A, Merica R, Zell T, Jenkins MK. Visualizing the generation of memory CD4 T cells in the whole body. Nature doi:10.1038/35065111 (2001) 410(6824):101-5.
22. Hogan RJ, Zhong W, Usherwood EJ, Cookenham T, Roberts AD, Woodland DL. Protection from respiratory virus infections can be mediated by antigen-specific CD4(+) T cells that persist in the lungs. J Exp Med doi:10.1084/jem.193.8.981 (2001) 193(8):981-6.
23. Bingaman AW, Patke DS, Mane VR, Ahmadzadeh M, Ndejembi M, Bartlett ST, et al. Novel phenotypes and migratory properties distinguish memory CD4 T cell subsets in lymphoid and lung tissue. Eur J Immunol doi:10.1002/eji.200526004 (2005) 35:3173-86.
24. Price PW, Cerny J. Characterization of CD4+ T cells in mouse bone marrow. I. Increased activated/memory phenotype and altered TCR Vbeta repertoire. Eur J Immunol doi:10.1002/(SICI)1521-4141(199903)29:03<1051::AID-IMMU1051>3.0.CO;2-Y (1999) 29(3):1051-6.
25. Ibraghimov AR, Sacco RE, Sandor M, Iakoubov LZ, Lynch RG. Resident CD4+ alpha beta T cells of the murine female genital tract: a phenotypically distinct T cell lineage that rapidly proliferates in response to systemic T cell activation stimuli. Int Immunol doi:10.1093/intimm/7.11.1763 (1995) 7(11):1763-9.
26. 45R+) in both normal and diseased human skin. Arch Dermatol Res doi:10.1007/BF00424268 (1989) 281(1):24-30.
27. Campbell JJ, Murphy KE, Kunkel EJ, Brightling CE, Soler D, Shen Z, et al. CCR7 expression and memory T cell diversity in humans. J Immunol doi:10.4049/jimmunol.166.2.877 (2001) 166(2):877-84.
28. Clark RA, Chong B, Mirchandani N, Brinster NK, Yamanaka K, Dowgiert RK, et al. The vast majority of CLA+ T cells are resident in normal skin. J Immunol doi:10.4049/jimmunol.176.7.4431 (2006) 176(7):4431-9.
29. Kivisakk P, Mahad DJ, Callahan MK, Trebst C, Tucky B, Wei T, et al. Human cerebrospinal fluid central memory CD4+ T cells: evidence for trafficking through choroid plexus and meninges via P-selectin. Proc Natl Acad Sci U S A doi:10.1073/pnas.1433000100 (2003) 100(14):8389-94.
30. Zaid A, Mackay LK, Rahimpour A, Braun A, Veldhoen M, Carbone FR, et al. Persistence of skin-resident memory T cells within an epidermal niche. Proc Natl Acad Sci U S A doi:10.1073/pnas.1322292111 (2014) 111(14):5307-12.
31. Gebhardt T, Whitney PG, Zaid A, Mackay LK, Brooks AG, Heath WR, et al. Different patterns of peripheral migration by memory CD4+ and CD8+ T cells. Nature doi:10.1038/nature10339 (2011) 477(7363):216-9.
32. Anderson KG, Mayer-Barber K, Sung H, Beura L, James BR, Taylor JJ, et al. Intravascular staining for discrimination of vascular and tissue leukocytes. Nat Protoc doi:10.1038/nprot.2014.005 (2014) 9(1):209-22.
33. Turner DL, Gordon CL, Farber DL. Tissue-resident T cells, in situ immunity and transplantation. Immunol Rev doi:10.1111/imr.12149 (2014) 258(1):150-66.
34. Purwar R, Campbell J, Murphy G, Richards WG, Clark RA, Kupper TS. Resident memory T cells (T(RM)) are abundant in human lung: diversity, function, and antigen specificity. PLoS One doi:10.1371/journal.pone.0016245 (2011) 6(1):e16245.
35. Herndler-Brandstetter D, Landgraf K, Jenewein B, Tzankov A, Brunauer R, Brunner S, et al. Human bone marrow hosts polyfunctional memory CD4+ and CD8+ T cells with close contact to IL-15-producing cells. J Immunol doi:10.4049/jimmunol.1100243 (2011) 186(12):6965-71.
36. Farber DL, Yudanin NA, Restifo NP. Human memory T cells: generation, compartmentalization and homeostasis. Nat Rev Immunol doi:10.1038/nri3567 (2014) 14(1):24-35.
37. Chapman TJ, Topham DJ. Identification of a unique population of tissue-memory CD4+ T cells in the airways after influenza infection that is dependent on the integrin VLA-1. J Immunol doi:10.4049/jimmunol.0902281 (2010) 184(7):3841-9.
38. Tokoyoda K, Zehentmeier S, Hegazy AN, Albrecht I, Grun JR, Lohning M, et al. Professional memory CD4+ T lymphocytes preferentially reside and rest in the bone marrow. Immunity doi:10.1016/j.immuni.2009.03.015 (2009) 30(5):721-30.
39. de Bree GJ, Daniels H, Schilfgaarde M, Jansen HM, Out TA, van Lier RA, et al. Characterization of CD4+ memory T cell responses directed against common respiratory pathogens in peripheral blood and lung. J Infect Dis doi:10.1086/517612 (2007) 195(11):1718-25.
40. Connor LM, Harvie MC, Rich FJ, Quinn KM, Brinkmann V, Le Gros G, et al. A key role for lung-resident memory lymphocytes in protective immune responses after BCG vaccination. Eur J Immunol doi:10.1002/eji.200940279 (2010) 40(9):2482-92.
41. Thawer SG, Horsnell WG, Darby M, Hoving JC, Dewals B, Cutler AJ, et al. Lung-resident CD4(+) T cells are sufficient for IL-4Ralpha-dependent recall immunity to Nippostrongylus brasiliensis infection. Mucosal Immunol doi:10.1038/mi.2013.40 (2014) 7(2):239-48.
42. Koelle DM, Corey L, Burke RL, Eisenberg RJ, Cohen GH, Pichyangkura R, et al. Antigenic specificities of human CD4+ T-cell clones recovered from recurrent genital herpes simplex virus type 2 lesions. J Virol (1994) 68(5):2803-10.
43. Koelle DM, Frank JM, Johnson ML, Kwok WW. Recognition of herpes simplex virus type 2 tegument proteins by CD4 T cells infiltrating human genital herpes lesions. J Virol (1998) 72(9):7476-83.
44. Iijima N, Linehan MM, Zamora M, Butkus D, Dunn R, Kehry MR, et al. Dendritic cells and B cells maximize mucosal Th1 memory response to herpes simplex virus. J Exp Med doi:10.1084/jem.20082039 (2008) 205(13):3041-52.
45. Marzo AL, Vezys V, Williams K, Tough DF, Lefrancois L. Tissue-level regulation of Th1 and Th2 primary and memory CD4 T cells in response to Listeria infection. J Immunol doi:10.4049/jimmunol.168.9.4504 (2002) 168(9):4504-10.
46. Kawabe T, Sun SL, Fujita T, Yamaki S, Asao A, Takahashi T, et al. Homeostatic proliferation of naive CD4+ T cells in mesenteric lymph nodes generates gut-tropic Th17 cells. J Immunol doi:10.4049/jimmunol.1203111 (2013) 190(11):5788-98.
47. Cauley LS, Cookenham T, Miller TB, Adams PS, Vignali KM, Vignali DA, et al. Cutting edge: virus-specific CD4+ memory T cells in nonlymphoid tissues express a highly activated phenotype. J Immunol doi:10.4049/jimmunol.169.12.6655 (2002) 169(12):6655-8.
48. Woodland DL, Kohlmeier JE. Migration, maintenance and recall of memory T cells in peripheral tissues. Nat Rev Immunol doi:10.1038/nri2496 (2009) 9(3):153-61.
49. Wissinger EL, Stevens WW, Varga SM, Braciale TJ. Proliferative expansion and acquisition of effector activity by memory CD4+ T cells in the lungs following pulmonary virus infection. J Immunol doi:10.4049/jimmunol.180.5.2957 (2008) 180(5):2957-66.
50. Walrath J, Zukowski L, Krywiak A, Silver RF. Resident Th1-like effector memory cells in pulmonary recall responses to Mycobacterium tuberculosis. Am J Respir Cell Mol Biol doi:10.1165/rcmb.2005-0060OC (2005) 33(1):48-55.
51. Khader SA, Bell GK, Pearl JE, Fountain JJ, Rangel-Moreno J, Cilley GE, et al. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol doi:10.1038/ni1449 (2007) 8(4):369-77.
52. Chackerian AA, Perera TV, Behar SM. Gamma interferon-producing CD4+ T lymphocytes in the lung correlate with resistance to infection with Mycobacterium tuberculosis. Infect Immun doi:10.1128/IAI.69.4.2666-2674.2001 (2001) 69(4):2666-74.
53. McKinstry KK, Strutt TM, Kuang Y, Brown DM, Sell S, Dutton RW, et al. Memory CD4+ T cells protect against influenza through multiple synergizing mechanisms. J Clin Invest doi:10.1172/JCI63689 (2012) 122(8):2847-56.
54. Teijaro JR, Verhoeven D, Page CA, Turner D, Farber DL. Memory CD4 T cells direct protective responses to influenza virus in the lungs through helper-independent mechanisms. J Virol doi:10.1128/JVI.01069-10 (2010) 84(18):9217-26.
55. Walrath JR, Silver RF. The alpha4beta1 integrin in localization of Mycobacterium tuberculosis-specific T helper type 1 cells to the human lung. Am J Respir Cell Mol Biol doi:10.1165/rcmb.2010-0241OC (2011) 45(1):24-30.
56. Klein RS, Harris CA, Small CB, Moll B, Lesser M, Friedland GH. Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N Engl J Med doi:10.1056/NEJM198408093110602 (1984) 311(6):354-8.
57. Clift RA. Candidiasis in the transplant patient. Am J Med (1984) 77(4D):34-8.
58. Eriksson K, Bellner L, Gorander S, Lowhagen GB, Tunback P, Rydberg K, et al. CD4(+) T-cell responses to herpes simplex virus type 2 (HSV-2) glycoprotein G are type specific and differ in symptomatic and asymptomatic HSV-2- infected individuals. J Gen Virol doi:10.1099/vir.0.79978-0 (2004) 85(Pt 8):2139-47.
59. Harandi AM, Svennerholm B, Holmgren J, Eriksson K. Differential roles of B cells and IFN-gamma-secreting CD4(+) T cells in innate and adaptive immune control of genital herpes simplex virus type 2 infection in mice. J Gen Virol (2001) 82(Pt 4):845-53.
60. Koelle DM, Schomogyi M, Corey L. Antigen-specific T cells localize to the uterine cervix in women with genital herpes simplex virus type 2 infection. J Infect Dis doi:10.1086/315749 (2000) 182(3):662-70.
61. Feinen B, Jerse AE, Gaffen SL, Russell MW. Critical role of Th17 responses in a murine model of Neisseria gonorrhoeae genital infection. Mucosal Immunol doi:10.1038/mi.2009.139 (2010) 3(3):312-21.
62. Scurlock AM, Frazer LC, Andrews CW Jr, O'Connell CM, Foote IP, Bailey SL, et al. Interleukin-17 contributes to generation of Th1 immunity and neutrophil recruitment during Chlamydia muridarum genital tract infection but is not required for macrophage influx or normal resolution of infection. Infect Immun doi:10.1128/IAI.00984-10 (2011) 79(3):1349-62.
63. Gondek DC, Olive AJ, Stary G, Starnbach MN. CD4+ T cells are necessary and sufficient to confer protection against Chlamydia trachomatis infection in the murine upper genital tract. J Immunol doi:10.4049/jimmunol.1103032 (2012) 189(5):2441-9.
64. Pietrella D, Rachini A, Pines M, Pandey N, Mosci P, Bistoni F, et al. Th17 cells and IL-17 in protective immunity to vaginal candidiasis. PLoS One doi:10.1371/journal.pone.0022770 (2011) 6(7):e22770.
65. Hu J, Gardner MB, Miller CJ. Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells. J Virol doi:10.1128/JVI.74.13.6087-6095.2000 (2000) 74(13):6087-95.
66. Miller CJ, Li Q, Abel K, Kim EY, Ma ZM, Wietgrefe S, et al. Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus. J Virol doi:10.1128/JVI.79.14.9217-9227.2005 (2005) 79(14):9217-27.
67. Shale M, Schiering C, Powrie F. CD4(+) T-cell subsets in intestinal inflammation. Immunol Rev doi:10.1111/imr.12039 (2013) 252(1):164-82.
68. Mowat AM. Anatomical basis of tolerance and immunity to intestinal antigens. Nat Rev Immunol doi:10.1038/nri1057 (2003) 3(4):331-41.
69. Eberl G, Lochner M. The development of intestinal lymphoid tissues at the interface of self and microbiota. Mucosal Immunol doi:10.1038/mi.2009.114 (2009) 2(6):478-85.
70. Kilshaw PJ, Baker KC. A unique surface antigen on intraepithelial lymphocytes in the mouse. Immunol Lett doi:10.1016/0165-2478(88)90056-9 (1988) 18(2):149-54.
71. Cerf-Bensussan N, Jarry A, Brousse N, Lisowska-Grospierre B, Guy-Grand D, Griscelli C. A monoclonal antibody (HML-1) defining a novel membrane molecule present on human intestinal lymphocytes. Eur J Immunol doi:10.1002/eji.1830170910 (1987) 17(9):1279-85.
72. Russell GJ, Parker CM, Cepek KL, Mandelbrot DA, Sood A, Mizoguchi E, et al. Distinct structural and functional epitopes of the alpha E beta 7 integrin. Eur J Immunol doi:10.1002/eji.1830241138 (1994) 24(11):2832-41.
73. Ivanov II, Frutos Rde L, Manel N, Yoshinaga K, Rifkin DB, Sartor RB, et al. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe doi:10.1016/j.chom.2008.09.009 (2008) 4(4):337-49.
74. Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U, et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell doi:10.1016/j.cell.2009.09.033 (2009) 139(3):485-98.
75. Round JL, Mazmanian SK. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci U S A doi:10.1073/pnas.0909122107 (2010) 107(27):12204-9.
76. Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science doi:10.1126/science.1198469 (2011) 331(6015):337-41.
77. Atarashi K, Tanoue T, Oshima K, Suda W, Nagano Y, Nishikawa H, et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature doi:10.1038/nature12331 (2013) 500(7461):232-6.
78. Masopust D, Choo D, Vezys V, Wherry EJ, Duraiswamy J, Akondy R, et al. Dynamic T cell migration program provides resident memory within intestinal epithelium. J Exp Med doi:10.1084/jem.20090858 (2010) 207(3):553-64.
79. Poussier P, Edouard P, Lee C, Binnie M, Julius M. Thymus-independent development and negative selection of T cells expressing T cell receptor alpha/beta in the intestinal epithelium: evidence for distinct circulation patterns of gut- and thymus-derived T lymphocytes. J Exp Med doi:10.1084/jem.176.1.187 (1992) 176(1):187-99.
80. Mora JR. Homing imprinting and immunomodulation in the gut: role of dendritic cells and retinoids. Inflamm Bowel Dis doi:10.1002/ibd.20280 (2008) 14(2):275-89.
81. 2 cells. Nat Rev Immunol doi:10.1038/nri2870 (2010) 10(12):838-48.
82. 2 memory/effector cells that produce inflammatory IL-17 cytokine and promote the exacerbation of chronic allergic asthma. J Exp Med doi:10.1084/jem.20101376 (2010) 207(11):2479-91.
83. Holt PG, Strickland DH, Bosco A, Jahnsen FL. Pathogenic mechanisms of allergic inflammation: atopic asthma as a paradigm. Adv Immunol doi:10.1016/S0065-2776(08)04003-0 (2009) 104:51-113.
84. Baumgart DC, Sandborn WJ. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet doi:10.1016/S0140-6736(07)60751-X (2007) 369(9573):1641-57.
85. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature doi:10.1038/nature06005 (2007) 448(7152):427-34.
86. Nemoto Y, Kanai T, Kameyama K, Shinohara T, Sakamoto N, Totsuka T, et al. Long-lived colitogenic CD4+ memory T cells residing outside the intestine participate in the perpetuation of chronic colitis. J Immunol doi:10.4049/jimmunol.0803684 (2009) 183(8):5059-68.
87. Takahara M, Nemoto Y, Oshima S, Matsuzawa Y, Kanai T, Okamoto R, et al. IL-7 promotes long-term in vitro survival of unique long-lived memory subset generated from mucosal effector memory CD4+ T cells in chronic colitis mice. Immunol Lett doi:10.1016/j.imlet.2013.09.001 (2013) 156(1-2):82-93.
88. Conrad C, Boyman O, Tonel G, Tun-Kyi A, Laggner U, de Fougerolles A, et al. Alpha1beta1 integrin is crucial for accumulation of epidermal T cells and the development of psoriasis. Nat Med doi:10.1038/nm1605 (2007) 13(7):836-42.
89. Lowes MA, Kikuchi T, Fuentes-Duculan J, Cardinale I, Zaba LC, Haider AS, et al. Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol doi:10.1038/sj.jid.5701213 (2008) 128(5):1207-11.
90. Lewis BJ, Rajpara S, Haggart AM, Wilson HM, Barker RN, Ormerod AD. Predominance of activated, clonally expanded T helper type 17 cells within the CD4+ T cell population in psoriatic lesions. Clin Exp Immunol doi:10.1111/cei.12086 (2013) 173(1):38-46.
91. Boyman O, Hefti HP, Conrad C, Nickoloff BJ, Suter M, Nestle FO. Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-alpha. J Exp Med doi:10.1084/jem.20031482 (2004) 199(5):731-6.
92. Cheuk S, Wiken M, Blomqvist L, Nylen S, Talme T, Stahle M, et al. Epidermal Th22 and Tc17 cells form a localized disease memory in clinically healed psoriasis. J Immunol doi:10.4049/jimmunol.1302313 (2014) 192(7):3111-20.
93. Masopust D, Vezys V, Usherwood EJ, Cauley LS, Olson S, Marzo AL, et al. Activated primary and memory CD8 T cells migrate to nonlymphoid tissues regardless of site of activation or tissue of origin. J Immunol doi:10.4049/jimmunol.172.8.4875 (2004) 172(8):4875-82.
94. Agace WW. Tissue-tropic effector T cells: generation and targeting opportunities. Nat Rev Immunol doi:10.1038/nri1869 (2006) 6(9):682-92.
95. Lefrancois L, Puddington L. Intestinal and pulmonary mucosal T cells: local heroes fight to maintain the status quo. Annu Rev Immunol doi:10.1146/annurev.immunol.24.021605.090650 (2006) 24:681-704.
96. Iwata M, Hirakiyama A, Eshima Y, Kagechika H, Kato C, Song SY. Retinoic acid imprints gut-homing specificity on T cells. Immunity doi:10.1016/j.immuni.2004.08.011 (2004) 21(4):527-38.
97. Kunkel EJ, Campbell JJ, Haraldsen G, Pan J, Boisvert J, Roberts AI, et al. Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment: epithelial expression of tissue-specific chemokines as an organizing principle in regional immunity. J Exp Med doi:10.1084/jem.192.5.761 (2000) 192(5):761-8.
98. Berg EL, Yoshino T, Rott LS, Robinson MK, Warnock RA, Kishimoto TK, et al. The cutaneous lymphocyte antigen is a skin lymphocyte homing receptor for the vascular lectin endothelial cell-leukocyte adhesion molecule 1. J Exp Med doi:10.1084/jem.174.6.1461 (1991) 174(6):1461-6.
99. Mikhak Z, Strassner JP, Luster AD. Lung dendritic cells imprint T cell lung homing and promote lung immunity through the chemokine receptor CCR4. J Exp Med doi:10.1084/jem.20130091 (2013) 210(9):1855-69.
100. Kane CJ, Knapp AM, Mansbridge JN, Hanawalt PC. Transforming growth factor-beta 1 localization in normal and psoriatic epidermal keratinocytes in situ. J Cell Physiol doi:10.1002/jcp.1041440119 (1990) 144(1):144-50.
101. Koyama SY, Podolsky DK. Differential expression of transforming growth factors alpha and beta in rat intestinal epithelial cells. J Clin Invest doi:10.1172/JCI114080 (1989) 83(5):1768-73.
102. Wang D, Yuan R, Feng Y, El-Asady R, Farber DL, Gress RE, et al. Regulation of CD103 expression by CD8+ T cells responding to renal allografts. J Immunol doi:10.4049/jimmunol.172.1.214 (2004) 172(1):214-21.
103. Lee YT, Suarez-Ramirez JE, Wu T, Redman JM, Bouchard K, Hadley GA, et al. Environmental and antigen receptor-derived signals support sustained surveillance of the lungs by pathogen-specific cytotoxic T lymphocytes. J Virol doi:10.1128/JVI.02493-10 (2011) 85(9):4085-94.
104. Masopust D, Vezys V, Wherry EJ, Barber DL, Ahmed R. Cutting edge: gut microenvironment promotes differentiation of a unique memory CD8 T cell population. J Immunol doi:10.4049/jimmunol.176.4.2079 (2006) 176(4):2079-83.
105. Ziegler SF, Ramsdell F, Alderson MR. The activation antigen CD69. Stem Cells doi:10.1002/stem.5530120502 (1994) 12(5):456-65.
106. Freeman BE, Hammarlund E, Raue HP, Slifka MK. Regulation of innate CD8+ T-cell activation mediated by cytokines. Proc Natl Acad Sci U S A doi:10.1073/pnas.1203543109 (2012) 109(25):9971-6.
107. Sun S, Zhang X, Tough DF, Sprent J. Type I interferon-mediated stimulation of T cells by CpG DNA. J Exp Med doi:10.1084/jem.188.12.2335 (1998) 188(12):2335-42.
108. Zammit DJ, Turner DL, Klonowski KD, Lefrancois L, Cauley LS. Residual antigen presentation after influenza virus infection affects CD8 T cell activation and migration. Immunity doi:10.1016/j.immuni.2006.01.015 (2006) 24(4):439-49.
109. Kim TS, Hufford MM, Sun J, Fu YX, Braciale TJ. Antigen persistence and the control of local T cell memory by migrant respiratory dendritic cells after acute virus infection. J Exp Med doi:10.1084/jem.20092017 (2010) 207(6):1161-72.
110. Bankovich AJ, Shiow LR, Cyster JG. CD69 suppresses sphingosine 1-phosophate receptor-1 (S1P1) function through interaction with membrane helix 4. J Biol Chem doi:10.1074/jbc.M110.123299 (2010) 285(29):22328-37.
111. Matloubian M, Lo CG, Cinamon G, Lesneski MJ, Xu Y, Brinkmann V, et al. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature doi:10.1038/nature02284 (2004) 427(6972):355-60.
112. Guthrie T, Hobbs CG, Davenport V, Horton RE, Heyderman RS, Williams NA. Parenteral influenza vaccination influences mucosal and systemic T cell-mediated immunity in healthy adults. J Infect Dis doi:10.1086/425517 (2004) 190(11):1927-35.
113. Lanthier PA, Huston GE, Moquin A, Eaton SM, Szaba FM, Kummer LW, et al. Live attenuated influenza vaccine (LAIV) impacts innate and adaptive immune responses. Vaccine doi:10.1016/j.vaccine.2011.07.093 (2011) 29(44):7849-56.
114. Hammitt LL, Bartlett JP, Li S, Rahkola J, Lang N, Janoff EN, et al. Kinetics of viral shedding and immune responses in adults following administration of cold-adapted influenza vaccine. Vaccine doi:10.1016/j.vaccine.2009.09.041 (2009) 27(52):7359-66.
115. Trunz BB, Fine P, Dye C. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet doi:10.1016/S0140-6736(06)68507-3 (2006) 367(9517):1173-80.
116. Tameris MD, Hatherill M, Landry BS, Scriba TJ, Snowden MA, Lockhart S, et al. Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial. Lancet doi:10.1016/S0140-6736(13)60177-4 (2013) 381(9871):1021-8.
117. Tameris M, Geldenhuys H, Luabeya AK, Smit E, Hughes JE, Vermaak S, et al. The candidate TB vaccine, MVA85A, induces highly durable Th1 responses. PLoS One doi:10.1371/journal.pone.0087340 (2014) 9(2):e87340.
118. Tchilian EZ, Desel C, Forbes EK, Bandermann S, Sander CR, Hill AV, et al. Immunogenicity and protective efficacy of prime-boost regimens with recombinant (delta)ureC hly+ Mycobacterium bovis BCG and modified vaccinia virus Ankara expressing M. tuberculosis antigen 85A against murine tuberculosis. Infect Immun doi:10.1128/IAI.00685-08 (2009) 77(2):622-31.
119. Williams A, Hatch GJ, Clark SO, Gooch KE, Hatch KA, Hall GA, et al. Evaluation of vaccines in the EU TB vaccine cluster using a guinea pig aerosol infection model of tuberculosis. Tuberculosis (Edinb) doi:10.1016/j.tube.2004.09.009 (2005) 85(1-2):29-38.
120. Vordermeier HM, Villarreal-Ramos B, Cockle PJ, McAulay M, Rhodes SG, Thacker T, et al. Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis. Infect Immun doi:10.1128/IAI.00287-09 (2009) 77(8):3364-73.
121. Verreck FA, Vervenne RA, Kondova I, van Kralingen KW, Remarque EJ, Braskamp G, et al. MVA.85A boosting of BCG and an attenuated, phoP deficient M. tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaques. PLoS One doi:10.1371/journal.pone.0005264 (2009) 4(4):e5264.
122. Lin PL, Dietrich J, Tan E, Abalos RM, Burgos J, Bigbee C, et al. The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection. J Clin Invest doi:10.1172/JCI46252 (2012) 122(1):303-14.
123. Zhu J, Hladik F, Woodward A, Klock A, Peng T, Johnston C, et al. Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition. Nat Med doi:10.1038/nm.2006 (2009) 15(8):886-92.
124. Huang W, Hu K, Luo S, Zhang M, Li C, Jin W, et al. Herpes simplex virus type 2 infection of human epithelial cells induces CXCL9 expression and CD4+ T cell migration via activation of p38-CCAAT/enhancer-binding protein-beta pathway. J Immunol doi:10.4049/jimmunol.1103706 (2012) 188(12):6247-57.
125. Manrique M, Kozlowski PA, Wang SW, Wilson RL, Micewicz E, Montefiori DC, et al. Nasal DNA-MVA SIV vaccination provides more significant protection from progression to AIDS than a similar intramuscular vaccination. Mucosal Immunol doi:10.1038/mi.2009.103 (2009) 2(6):536-50.